46% of Karnataka was Covid Infected by August: Sero Survey Report

Nov 10, 2020

2036 Views


Rural areas affected nearly as much as urban ones due to return of migrants, private survey found

Published: 10th November 2020 05:29 AM  |   Last Updated: 10th November 2020 05:29 AM

By Ranjani MadhavanExpress News Service

BENGALURU: Nearly half of Karnataka’s population was infected by Covid-19 by August – not just in urban areas, but in the villages too – according to a private serosurvey conducted between mid-June and August.Adjusted seroprevalence implies that approximately 31.5 million of Karnataka’s residents – or 46.7% – were infected by the virus in the past. This is 96.4 times the number of cases – 3.27 lakh – reported by Department of Health by August 29. A serosurvey is used to estimate the prevalence of antibodies against a specific infectious pathogen as an indicator of immunity. 

The IDFC Institute released the findings of the seroprevalence survey by experts at Duke University, University of Chicago, MapmyGenome and Center for Monitoring Indian Economy. It was funded by ACT Grants. 

Other findings 
Adjusted seroprevalence in rural Karnataka was 44.1% and 53.8% in urban areas, while it was 46.7% for the state as a whole, suggesting that rural areas were almost equally affected, contrary to the perception that only urban areas would be more vulnerable to Covid-19 due to higher population density. However, rural areas received millions of migrant workers fleeing cities and agriculture was an essential-activity exempt from lockdown.

Between 1.5% and 1.7% in rural areas and 4% and 10.5% in urban areas tested positive on a RT-PCR test, indicating rapid spread of the disease. “Our data show evidence of high levels of active infections and transmission, especially in urban areas of Mysuru and coastal districts during our study period where 9.7-0.5% of individuals tested positive for current infection,” said Anup Malani, professor at Pritzker School of Medicine, University of Chicago, and one of the researchers of the study.

Sampling and methodology
The study used ELISA tests to detect the presence of antibodies specific to Covid-19 and ran pooled RT-PCR tests to determine current infections. The study sample comprised 2,912 households across 20 districts drawn from an existing, representative sample of a panel survey, the Center for Monitoring Indian Economy’s Consumer Pyramids Household Survey. 

Areas were divided into 5 homogenous regions (HR) – Bengaluru HR, Belagavi HR, Kalaburagi HR, Mysuru HR and Coastal HR – that is an area comprised of neighbouring districts in a state which have similar agro-climatic conditions, urbanization rates, and female literacy. Anu Acharya, CEO of MapmyGenome said the sample size represented every kind of person in the state, and people of all economic strata from urban and rural areas. 

Recommendations
Dr. Manoj Mohanan, associate professor at Sanford School of Public Policy at Duke University, and one of the researchers, said these findings do not suggest under-reporting of cases. “The findings imply that there is not enough random testing, to find the true number of cases. For example, of 5 neighbours who are positive, only one is symptomatic and will be detected, while the others go unreported. Around 90-95% of India’s population is asymptomatic. The state can make a policy decision to have random testing at targeted places,” Mohanan said, adding that there is a need to focus on people who can spread the disease and not just patients. 

The report said there was a “strong case for adopting frequent testing in exchange for permitting productive economic activity. A total relaxation could lead to a spike in infections among such at-risk populations leading to further spikes in severe cases or mortality, and that will create a large burden for the health system. Therefore… it is critical to continue efforts to promote mask wearing, hand washing, and communicating the significance of COVID complications to individuals who are at risk.”

Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.